Safety of proteasome inhibitors for treatment of multiple myeloma
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1080/14740338.2017.1259310
Reference68 articles.
1. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
2. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
3. Crystal Structure of the Boronic Acid-Based Proteasome Inhibitor Bortezomib in Complex with the Yeast 20S Proteasome
4. Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non-peptidic immunoproteasome β5i-selective inhibitor as potential treatment for idiopathic pulmonary fibrosis: Virtual screening, hit evolution and lead identification;European Journal of Medicinal Chemistry;2023-12
2. SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses;Frontiers in Cell and Developmental Biology;2023-05-25
3. Selective noncovalent proteasome inhibiting activity of trifluoromethyl‐containinggem‐quaternary aziridines;Archiv der Pharmazie;2023-04-29
4. The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell–mediated graft-versus-host disease;Blood;2023-03-23
5. Bortezomib-Induced Bilateral Eye Swelling and Cutaneous Adverse Reaction in a Patient with Plasma Cell Leukemia—A Case Report;Case Reports in Clinical Medicine;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3